Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19
Conditions
Interventions
- DRUG: Pioglitazone 30 mg
- OTHER: standard of care
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal